2019 Faculty

The IOTOD conference partners with internationally-renowned faculty from a variety of backgrounds and specialities.

The faculty includes experts in cutting-edge opioid dependence treatment research, comorbid pain, overdose prevention strategies, hepatitis C elimination and much more.

The currently confirmed faculty for IOTOD 2019 are displayed below.

Scientific Committee

Professor Jens Reimer

University Medical Center Hamburg

Hamburg, Germany

Dr Elisabeth Avril

Gaia Paris

Paris, France

Mr Duncan Hill

Specialist Pharmacist in Substance Misuse, NHS Lanarkshire

Glasgow, Scotland

Professor Graham Foster

Professor of Hepatology, Queen Mary's University of London & Consultant, Bart's Health NHS Trust

London, UK


Speakers

Mr Mat Southwell

European Network of People who Use Drugs (EuroNPUD)

Bath, UK

Dr Ricardo Baptista-Leite

Portuguese National Parliament

Lisbon, Portugal

Professor Jens Reimer

University Medical Center Hamburg

Hamburg, Germany

Dr Magdalena Harris

London School of Hygiene and Tropical Medicine

London, UK

Dr Elisabeth Avril

Gaia Paris

Paris, France

Dr Yasir Abbasi

Mersey Care NHS Foundation Trust and the University of Liverpool

Liverpool, UK

Dr Vana Sypsa

National and Kapodistrian University of Athens

Athens, Greece

Dr Sara-Ara Ahmed

Ahmed Institute for Pain & Cannabinoid Research

Calgary, Canada

Dr Stephan Walcher

Director, Concept Centre for Addiction Medicine

Munich, Germany

Professor Nicholas Lintzeris

Director, Drug and Alcohol Services, South East Sydney Local Health District

Sydney, Australia

Mr Duncan Hill

Specialist Pharmacist in Substance Misuse, NHS Lanarkshire

Glasgow, Scotland

Professor Graham Foster

Professor of Hepatology, Queen Mary's University of London & Consultant, Bart's Health NHS Trust

London, UK

Professor Ashley Brown

Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, and Professor of Practice (Viral Hepatitis), Imperial College London

London, UK

Reports

Achieving HCV elimination
Hepatitis C Virus (HCV) Complexities and comorbidities in HCV care
View all reports